Advertisement

Inpharma Weekly

, Volume 1661, Issue 1, pp 19–19 | Cite as

US FDA adds 3 months to dexlansoprazole NDA.

Media release
  • 3 Downloads

Keywords

Drug User Pharmaceutical Company Gastroesophageal Reflux Medium Release Reflux Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations